Quest Diagnostics Acquires Cleveland HeartLab, Formalizes R&D Collaboration

We represented Quest Diagnostics (NYSE: DGX) in its acquisition of Cleveland HeartLab. The acquisition combines the expertise of Cleveland HeartLab’s personalized evaluation of heart disease risk based on inflammation and other markers with Quest’s Cardio IQ® lipid particle analysis and genetic and metabolic testing leadership. In connection with the acquisition, Quest Diagnostics and Cleveland Clinic have also finalized a strategic collaboration intended to speed the commercialization of emerging innovations at Cleveland Clinic, including its Lerner Research Institute. Terms of the transaction were not publicly disclosed.

Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions.

You Also May Be Interested In:

  • We served as Tennessee regulatory counsel for Caregiver, Inc., a provider of community-based services and support to more than three thousand individuals with intellectual and developmental disabilities across Texas, Tennessee, Indiana, and Ohio, in its recapitalization by WindRose Health Investors, LLC

    We served as Tennessee regulatory counsel for Caregiver, Inc., a provider of community-based services and support to more than three...
    Client Type: Private Company
  • Representation of Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, in its definitive agreement to sell certain assets of Passport Health Plan, including Passport’s brand, operational and clinical infrastructure, and certain provider and vendor agreements, to Molina Healthcare, Inc.

    We represented Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers...
    Client Type: Public Company
  • Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm

    We represented Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based...
    Client Type: Private Company